Search - tctmd.com

Displaying 81 - 100 of 372

Sort: Relevancy | Date

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

February 22, 2022

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

News Daily News

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

January 25, 2022

COVID-19: TCTMD’s Dispatch for January Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 3

January 17, 2022

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

News Daily News

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

January 14, 2022

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

News Daily News

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

January 06, 2022

COVID-19: TCTMD’s Dispatch for December Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 3

December 20, 2021

Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis

News Daily News

Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis

Yael L. Maxwell

November 23, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

September 07, 2021

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

News Daily News

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

August 20, 2021

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

News Daily News

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

August 06, 2021

White Coat Beats Casuals in Patient Perceptions, With Gender Caveats

News Daily News

White Coat Beats Casuals in Patient Perceptions, With Gender Caveats

Yael L. Maxwell

August 02, 2021

Latest Smartphones Likely Pose Little Risk to Patients With ICDs

News Daily News

Latest Smartphones Likely Pose Little Risk to Patients With ICDs

July 28, 2021

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

July 12, 2021

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

June 29, 2021

AHA Advice For Rare But Deadly Mechanical Complications of Acute MI

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

June 18, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.